VERMICULITE SPECIALTY LLC – Trademark Portfolio

Entity Type: 16

VERMICULITE SPECIALTY LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 3 filings in this category. The portfolio also extends into Class 19 (Building Materials) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MICROLITE. The owner is based in BALA CYNWYD, PA.

1 BALA AVENUE

SUITE 310

BALA CYNWYD, PA 19004

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

VERMICULITE SPECIALTY LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (3 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

19
Building Materials (1 filing)

Building materials (non-metallic); non-metallic rigid pipes for building

Frequently Asked Questions

How many trademarks does VERMICULITE SPECIALTY LLC have?

VERMICULITE SPECIALTY LLC has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 cancelled.

What trademark classes does VERMICULITE SPECIALTY LLC file in?

VERMICULITE SPECIALTY LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 19 (Building Materials). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are VERMICULITE SPECIALTY LLC's most well-known trademarks?

VERMICULITE SPECIALTY LLC's registered trademark portfolio includes well-known marks such as MICROLITE. These are among 1 currently registered trademark in the portfolio.

What is VERMICULITE SPECIALTY LLC's trademark registration success rate?

VERMICULITE SPECIALTY LLC has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.